ArticleFrontiers in oncology2026

Artificial neural network-based immune biomarker signature predicts pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer.

Yulong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.